Uncover key drivers, emerging technologies, and competitive movements shaping the gastric cancer diagnostic procedure market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Gastric Cancer Diagnostic Procedure Market be in 2030 compared with 2026?
The gastric cancer diagnostic procedure market has seen robust growth in recent years. Its size is anticipated to expand from $1.54 billion in 2025 to $1.65 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.4%. The historical expansion of this market can be attributed to the utilization of endoscopy in gastric diagnosis, the increased adoption of biopsy procedures, the availability of various imaging tests, established hospital-based diagnostic infrastructure, and the ongoing development of pathology laboratories.
The gastric cancer diagnostic procedure market size is anticipated to experience substantial expansion over the upcoming years. Projections indicate it will reach $2.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.7%. This anticipated growth during the forecast period is propelled by factors such as the rise of liquid biopsy techniques, the broadening scope of molecular diagnostics, the persistent need for early detection, increased automation in diagnostic processes, and the utilization of AI-enabled imaging analysis. Key developments expected in this period encompass the increasing application of endoscopic diagnostic techniques, the growing acceptance of molecular and genetic testing, a heightened call for identifying cancer in its early stages, the proliferation of non-invasive diagnostic methods, and the incorporation of sophisticated imaging technologies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12038&type=smp
What Drivers Are Guiding Growth Patterns In The Gastric Cancer Diagnostic Procedure Market?
The increasing prevalence of smoking is projected to fuel expansion within the gastric cancer diagnostic procedure market. Smoking involves the inhalation and exhalation of smoke from burning tobacco or other substances. For individuals with a history of smoking or those susceptible to smoking-related cancers, gastric cancer diagnostic procedures are vital for early detection and identifying precancerous lesions, aiding in the development of personalized treatment plans, improving communication and coordination, and offering a thorough evaluation of the gastric mucosa and adjacent tissues. For example, a July 2023 report from the World Health Organization, an intergovernmental organization based in Switzerland, highlighted that over 8 million people die annually due to tobacco, including 1.3 million non-smokers exposed to second-hand smoke. Consequently, the escalating trend in smoking is a key driver for the growth of the gastric cancer diagnostic procedure market.
How Is The Gastric Cancer Diagnostic Procedure Market Divided Into Segments?
The gastric cancer diagnostic procedure market covered in this report is segmented –
1) By Procedure Type: Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types
2) By Symptom Type: Symptomatic, Asymptomatic
3) By Offering Type: Instruments, Reagents And Consumables, Services
4) By Body Fluid Type: Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid
5) By Disease Indication: Early Gastric Cancer, Advanced Gastric Cancer
Subsegments:
1) By Endoscopic Procedure: Upper Endoscopy (EGD), Endoscopic Ultrasound (EUS)
2) By Biopsy: Endoscopic Biopsy, Fine Needle Aspiration (FNA) Biopsy
3) By Tissue Tests: Histopathology, Immunohistochemistry
4) By Lab Tests: Blood Tests, Tumor Markers
5) By In-Vitro Diagnostic Tests: Genetic Testing, Molecular Profiling
6) By Imaging Tests: Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scan
7) By Molecular Diagnostics: PCR Testing, Next-Generation Sequencing (NGS)
8) By Multiplexing Molecular Diagnostics: Multiplex PCR, Microarray Analysis
9) By Immunoassays: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA)
10) By Other Procedure Types: Breath Tests, Liquid Biopsies
What Long-Term Trends Are Expected To Shape The Future Of The Gastric Cancer Diagnostic Procedure Market?
Companies operating significantly within the gastric cancer diagnostic procedure market are prioritizing technological advancements, including dual cell-free and exosomal miRNA liquid biopsy assays, to secure a competitive edge. These assays function by quantifying small noncoding RNAs found freely in the bloodstream and also contained within tumor-derived exosomes, thereby enabling highly sensitive and specific identification of gastric cancer from a simple blood sample. For instance, in December 2024, Cizzle Bio, a U.S.-based biotechnology company, introduced its DEX G2 blood test. This test integrates cell-free and exosomal miRNAs to achieve approximately 95% sensitivity and 97% specificity, only requiring a standard blood draw rather than an invasive endoscopy. This innovation promises earlier diagnosis and a wider screening reach, though broad adoption might be restricted by regulatory approval schedules and the necessity for real-world validation.
Which Key Players Are Driving Competition In The Gastric Cancer Diagnostic Procedure Market?
Major companies operating in the gastric cancer diagnostic procedure market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Myriad Genetics Inc., Foundation Medicine Inc., Biocept Inc., Illumina Inc., Roche Diagnostics, QIAGEN N V, Bio-Rad Laboratories Inc., Siemens Healthineers, Danaher Corporation, Becton Dickinson, bioMérieux SA, PerkinElmer Inc., NeoGenomics Laboratories, Guardant Health Inc., Natera Inc., Caris Molecular Diagnostics, Adaptive Biotechnologies Corp, 10x Genomics Inc
Access The Complete Report For Deeper Market Insights:
How Does The Gastric Cancer Diagnostic Procedure Market Perform Across Major Global Regions?
North America was the largest region in the gastric cancer diagnostics procedure market in 2025. The regions covered in the gastric cancer diagnostic procedure market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gastric Cancer Diagnostic Procedure Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=12038&type=smp
Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Procedure Market 2026, By The Business Research Company
Cancer Diagnostics Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report
Gastric Cancer Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastric-cancer-drugs-global-market-report
Gastric Ulcers Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model